Raf-1-induced cell cycle arrest in LNCaP human prostate cancer cells

Journal of Cellular Biochemistry

Volumn 72, Issue 4, 1999, Pages 458-469

  Ravi, Rajani K ^a   McMahon, Martin ^b   Yangang, Zang ^a   Williams, Jerry R ^a   Dillehay, Larry E ^a   Nelkin, Barry D ^a   Mabry, Mack ^a,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Matrix Pharmaceutical Inc   (United States)

Author keywords

Activated Raf; Cell cycle; MAP kinase; p21(WAF1 CIP1); SA galactosidase

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P21; RAF PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; MOLECULAR CLONING; PRIORITY JOURNAL; PROSTATE CANCER; RNA ANALYSIS; SENESCENCE;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL AGING; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; HISTOCYTOCHEMISTRY; HUMANS; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-RAF; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033559698     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C     Document Type: Article

References (50)

1. Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. 1995. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 270:19181-19187.
2. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD098059 is a specific inhibitor of the mitogen-activated protein kinase kinase in vitro and vivo. J Biol Chem 270:27489-27494.
3. Avruch J, Xhang X-F, Kyriakis JM. 1994. Raf meets ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci 19:279-283.
4. Blagosklonny MV, Prabhu NS, el-Deiry WS. 1997. Defects in p21WAF1/CIP1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells. Cancer Res 57:320-325.
5. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H. 1990. Suppression of tumorigenicity of human prostate carcinoma cell by replacing a mutated RB gene. Science 247: 712-715.
6. Carroll AG, Voeller HJ, Sugars L, Gelmann EP. 1993. p53 oncogene mutations in three human prostate cancer cell lines. Prostate 23:123-134.
7. Carson EB, McMahon M, Baylin S, Nelkin BD. 1995. Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation. Cancer Res 55:2048-2052.
8. Carter BS, Epstein JI, Isaacs WB. 1990. ras gene mutations in human prostate cancer. Cancer Res 50:6830-6832.
9. Celano P, Berchtold C, Cassero RA Jr. 1989. A simplification of the nuclear run-off transcription assay. Biotechniques 7:942-944.
10. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Cowley S, Paterson H, Kemp P, Marshall CJ. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841-852.
12. Davies P, Eaton Cl. 1991. Regulation of prostate growth. J Endocrinol 131:5-17.
13. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medranos EE, Linskens M, Rubelj I, Pereira-Smith OM, Peacocke M, Campisi J. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367.
14. Elo JP, Kvist L, Leinonen K, Isomaa V, Henttu P, Lukkarinen O, Vihko P. 1995. Mutated human androgen receptor gene detected in prostatic cancer patient is also activated by estradiol. J Clin Endocrinol Metab 80:3494-3500.
15. 1 cyclin-dependent kinases. Cell 75:805-816.
16. Isaacs JT. 1987. Development and characteristics of available model systems for the study of prostate cancer. In: Coffey DS, et al., editors. Current concepts and approaches to the study of prostate cancer. Prog Clin Biol Res 239:513-576.
17. King RW, Jackson PK, Kirschner MW. 1994. Mitosis in transition. Cell 79:563-571.
18. Kuo W-L, Abe M, Rhee J, Eves EM, McCarthy SS, Van M, Templeton DJ, McMahon M, Rosner MR. 1996. Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells. Mol Cell Biol 16:1458-1470.
19. Li H, Kawasaki H, Nishida E, Hattori S, Nakamura S. 1996. Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells. J Neurochem 66:2287-2294.
20. Li X-S, Rishi AK, Shoa Z-M, Dawson ML, Jong I, Shroot B, Reichert U, Ordonez J, Fontana J. 1996. Posttranscriptional regulation of p21WAF1/CIP1 expression in human breast carcinoma cell. Cancer Res 56:5055-5062.
21. Liu Y, Martindale JL, Gorospe M, Holbrook NJ. 1996. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase pathway. Cancer Res 56: 31-35.
22. Lloyd AC, Obermuller F, Staddon S, Earth CF, McMahon M, Land H. 1997. Co-operating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 11:663-677.
23. Mabry M, Nakagawa T, Baylin S, Pettengill O, Sorenson G, Nelkin BD. 1989. Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. J Clin Invest 84:194-199.
24. Marshall M. 1995. Interactions between ras and raf: Key regulatory proteins in cellular transformation. Mol Reprod Dev 42:493-499.
25. Morgan DO. 1995. Principles of CDK regulation. Nature 374:131-134.
26. Morrison DK, Cutler RE. 1997. The complexity of Raf-1 regulation. Curr Opin Cell Biol 9:174-179.
27. Nakagawa T, Mabry M, De Bustros A, Ihle N, Nelkin BD, Baylin S. 1987. Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci USA 84:5923-5927.
28. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15:2612-2624.
29. Waf1/Cip1. Nature 394:294-299.
30. Paggi MG, Baldi A, Bonetto F, Giordano A. 1996. Retinoblastoma protein family in cell cycle and cancer: A review. J Cell Biochem 62:418-430.
31. Pergolizzi RG, Kreis W, Rottach C, Susin M, Broome JD. 1993. Mutational status of codons 12 and 13 of the N-and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas. Cancer Invest 11: 25-32.
32. Pumiglia KM, Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448-452.
33. Ridley AJ, Paterson HF, Noble M, Land H. 1988. Rasmediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J 7:1635-1645.
34. Samuels ML, Weber MJ, Bishop M, McMahon M. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 13:6241-6252.
35. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
36. WAF1/CIP1/SDI1 in differentiating human leukemic cells. J Clin Invest 95:973-979.
37. INK4a. Cell 88:593-602.
38. Sewing A, Wiseman B, Lloyd AC, Land H. 1997. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17:5588-5597.
39. Sherr CJ. 1996. Cancer cell cycles. Science 274:1672-1677.
40. Sherr CJ, Roberts JM. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163.
41. Smith JR, Pereira-Smith OM. 1996. Replicative senescence: Implications for in vivo aging and tumor suppression. Science 273:63-66.
42. Stein GH, Dulic V. 1995. Origins of G1 arrest in senescent human fibroblasts. BioEssays 17:537-543.
43. Tsai L-H, Lees E, Faha B, Harlow E, Riabowol K. 1993. The cdk2 kinase is required for the G1-S transition in mammalian cells. Oncogene 8:1593-1602.
44. Vindelov LL, Christensen IJ, Nissen NI. 1983. A detergent-trypsin method for the preparation of nuclei for flow cytomatric DNA analysis. Cytometry 3:323-327.
45. Waga S, Hannon GJ, Stillman B. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-577.
46. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
47. Williams NG, Roberts TM. 1994. Signal transduction pathways involving the Raf proto-oncogene. Cancer Metast Rev 13:105-116.
48. ip1. Mol Cell Biol 17:5598-5611.
49. Wood KW, Qi H, D'Arcangelo G, Armstrong RC, Roberts TM, Halegoua S. 1993. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells. A potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc Natl Acad Sci USA 90:5016-5020.
50. Zeng YX, el-Deiry WS. 1996. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564.